Downregulation of TTL and increased α-tubulin detyrosination were reported during the epithelial–mesenchymal transition (EMT) that occurs during tumor invasion [245] in prostate cancer cells [246], in aggressive subtypes of breast cancer cells [247], and in primary neuroblastomas with poor prognosis [248]. The gene discussed is TTL; the disease is neoplasm.